BioPlex 2200 Instrument Rhodamine Solution

SECTION 2: Hazards identification

HAZARDOUS COMPONENTS This test kit should be handled only by qualified personnel trained in laboratory procedures and familiar with their potential hazards. Specific warnings are given in the instructions for use. The absence of a specific warning should not be interpreted as an indication of safety. The following information is furnished for those product hazardous constituents that require regulatory control or disclosure at the concentration found in the product. Refer to Section 16 for the full text of any solely abbreviated or coded hazard statements provided below and for the key / legend to abbreviations and acronyms. Component *

Contains

BioPlex 2200 - Phosphate buffered saline solution with < 0.2% Rhodamine [C28H31N2O3Cl], CAS# 81-88-9, EC No 201-383-9. Not subject to GHS, US HCS, EC CLP and analogous global GHS-based regulatory requirements in this product mixture and Rhodamine concentration. Solution, - Preserved with 0.034% ProClin 300 (< 0.001% active ingredient), EC Index No 613-167-00-5 with CAS# 55965-84-9. Not 10 mL subject to GHS, US HCS, and analogous global GHS-based regulatory requirements in this product mixture and concentration. EC CLP: EUH208 – Contains < 0.05%, but ≥ 0.005% ProClin 300 (0.0015% - 0.00015% active ingredient). May produce and allergic reaction. - Preserved with < 0.1% sodium azide [NaN3], CAS# 26628-22-8 and EC No 247-852-1. Not subject to GHS, US HCS, EC CLP and analogous global GHS-based regulatory requirements in this product mixture and concentration. * Not for distribution to customers. For Bio-Rad Service Personnel use only. Markings according to the United Nations (UN) Globally Harmonized System (GHS), United States Hazard Communication Standard (US HCS) and European Commission (EC) 2008/1272/EC (EC CLP) guidelines and analogous GHS-based global regulations: The chemical dilutions in this product are not subject to classification or labeling according United Nations (UN) GHS, United States Hazard Communication Standard (US HCS), and applicable analogous GHS-based global regulations. < 0.05% but ≥ 0.005 ProClin 300 [0.,0015 % - 0.00015 % active ingredients – reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one (C4H4ClNOS; CAS# 26172-55-4, EC No 247-500-7) and 2-methyl-2H -isothiazol-3-one (C4H5NOS; CAS# 2682-20-4, EC No 220-239-6) (3:1)], EC Index No 613-167-00-5 with CAS# 55965-84-9. Comprehensive GHS Based Classification: Dilution is not subject to GHS and US HCS labeling requirements. EUH208 – Contains < 0.05%, but ≥ 0.005 ProClin 300 (0.0015% - 0.00015% active ingredient). May produce and allergic reaction. [Source: Raw Material vendor SDS, CCOHS databases and regulatory research]